These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8655957)

  • 21. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection.
    Fernández I; Castellano G; Domingo MJ; Fuertes A; Colina F; Canga F; de la Cruz FJ; de la Cámara AG; Solís JA
    Scand J Gastroenterol; 1997 Jan; 32(1):70-6. PubMed ID: 9018770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus.
    Ito T; Mukaigawa J; Zuo J; Hirabayashi Y; Mitamura K; Yasui K
    J Gen Virol; 1996 May; 77 ( Pt 5)():1043-54. PubMed ID: 8609470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorimetric detection of competitive PCR products for quantification of hepatitis C viremia.
    Yun Z; Lundeberg J; Johansson B; Hedrum A; Weiland O; Uhlén M; Sönnerborg A
    J Virol Methods; 1994 Apr; 47(1-2):1-13. PubMed ID: 8051218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
    Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples.
    Gruppioni E; Vasuri F; Fiorentino M; Capizzi E; Altimari A; Pirini MG; Grazi GL; Malvi D; Grigioni WF; D'Errico-Grigioni A
    Diagn Mol Pathol; 2009 Dec; 18(4):232-8. PubMed ID: 19861893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue.
    Takehara T; Hayashi N; Mita E; Hagiwara H; Ueda K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1992 Mar; 15(3):387-90. PubMed ID: 1312054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells.
    Mellor J; Haydon G; Blair C; Livingstone W; Simmonds P
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():705-14. PubMed ID: 9568964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.
    Bjøro K; Krarup H; Bell H; Christophersen P; Evensen S; Frøland SS; Laursen A; B vd Lippe B; Maeland A; Ranek L
    Scand J Gastroenterol; 1995 Nov; 30(11):1119-24. PubMed ID: 8578174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
    Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK
    Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.
    Giostra F; Manzin A; Lenzi M; Francesconi R; Solforosi L; Manotti P; Muratori L; Zauli D; Clementi M; Bianchi FB
    J Hepatol; 1996 Oct; 25(4):433-8. PubMed ID: 8912141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus replication and antibodies to structural and nonstructural viral proteins in chronic hepatitis C.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Kasahara A; Fusamoto H; Kamada T
    J Hepatol; 1994 Mar; 20(3):421-5. PubMed ID: 7516952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C.
    Yun ZB; Sönnerborg A; Weiland O
    Scand J Gastroenterol; 1994 Jan; 29(1):82-6. PubMed ID: 8128182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver.
    Fukuda R; Ishimura N; Kushiyama Y; Moriyama N; Ishihara S; Nagasawa S; Miyake T; Niigaki M; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
    J Hepatol; 1997 Mar; 26(3):455-61. PubMed ID: 9075649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
    Shindo M; Arai K; Okuno T
    J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.